Dr. Braley is an Associate Professor of Neurology and clinical neuroimmunologist who specializes in the treatment of multiple sclerosis and related disorders. She received her MD from Wayne State University in 2004 and Master’s degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health in 2011. Dr. Braley’s research focuses on crucial connections between sleep disorders, the immune system, and neurological disorders (especially as they relate to patients with MS), and the treatment of chronic MS symptoms including fatigue. She also conducts clinical trials of MS therapeutics.
Since joining the U-M Neurology faculty in 2011, Dr. Braley has worked to develop a productive, multidisciplinary clinical research program between the University of Michigan Neurology Neuroimmunology (MS) and Sleep Divisions, and Physical Medicine and Rehabilitation Department. To date, these partnerships have led to several important findings that have increased our understanding of sleep disorders, including their effects on persons with MS, and predictors of MS-related fatigue. Dr. Braley has also established a new first of its kind Multidisciplinary MS Fatigue and Sleep Clinic. This clinic offers a unique service to patients with multiple sclerosis and related inflammatory disorders of the central nervous system.
To view publications authored, or co-authored, by Dr. Braley, visit Dr. Braley's page on PubMed (link is external).
Areas of Interest
Research: Dr. Braley is interested in neuroimmunology, multiple sclerosis clinical trial design, treatment of fatigue and pain in multiple sclerosis, as well as the diagnosis and treatment of sleep disorders in multiple sclerosis.
Tiffany Braley, M.D., M.S. , an associate professor of neurology at University of Michigan Health, was surprised when a patient she was caring for explained why they needed to go home from the hospital as soon as possible: their pets.
Principal investigators Tiffany Braley MD, MS (Neurology) and Anna Kratz PhD (Physical Medicine and Rehabilitation) were recently awarded $3.3M in new R01 funding from the National Center for Complimentary and Integrative Health to conduct research on the effects of cannabinoids on sleep and pain in people with MS.
Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men.
People with obstructive sleep apnea who treat their apnea with the commonly-prescribed positive airway pressure therapy were less likely to be diagnosed with dementia.
A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.
Medical School or Training
- MD, Wayne State University School of Medicine, 2004
- MS, University of Michigan School of Public Health, 2011
- University of Michigan Health System, Neurology, MI, 2008
- University of Michigan School of Public Health, Multiple Sclerosis, MI, 2011